Four physicians spoke on the panel, which was held at the Basketball Hall of Fame in Springfield, to discuss advancements in ...

Technology Networks spoke with Dr. Irina Babina, chief executive officer of Concr, to explore the origins of the company, the ...

CANCER remains a critical health challenge in Malaysia. This rising trend highlights the urgent need for effective ...

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...

If generative AI could contribute in the slightest to such discoveries—as has been promised since the start of the AI ...

DELFI Diagnostics, Inc., developer of innovative blood-based tests that leverage cell-free DNA (cfDNA) fragmentomics for cancer detection and monitoring, today announced its team is presenting at the ...

Now, we may know why zombie skin cells have this double agent-esque existence. Not all senescent skin cells are the same.

Breakthrough in bowel cancer research will speed up diagnosis: United Kingdom Friday, April 25, 2025, 16:00 Hrs [IST] Patients could soon benefit from world-leading technology to ...

Shares of NovoCure (NASDAQ: NVCR) are edging higher on Thursday. This muted reaction comes as the S&P 500 gained 0.3% and the Nasdaq Composite rose 0.6%. The medical technology company reported solid ...

Analysts, investors, and the media are invited to a presentation of RaySearch's interim report for the first quarter of 2025, on May 9, 2025, at 10.00 am CEST. The report will be published on May 9, ...

Researchers with City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U ...

Debiopharm further describes AbYlink as a one-step method that results in stable conjugation at defined and invariable sites on the Fc domain of an antibody, with no impact on antigen-binding regions, ...